Last reviewed · How we verify

NCT05782218: HULA

Healthy Unique Lipids From Almonds

Completed NA Last updated 28 November 2023
What this trial tests

NA trial testing Almonds in Nutrition, Healthy in 20 participants. Completed in 22 November 2023.

Timeline
31 March 2023
Primary endpoint
22 November 2023
22 November 2023

Quick facts

Lead sponsorUniversity of California, Davis
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment20
Start date31 March 2023
Primary completion22 November 2023
Estimated completion22 November 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, Davis

Who can join

Adults 18 to 50, any sex, with Nutrition, Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will address the notion that "healthy" lipids such as monounsaturated fatty acids in almonds can be used by the bacteria living in our gut to generate "new" molecules with potentially interesting health properties. This metabolite pattern is anticipated to differ significantly when compared to non-almond foods rich in saturated fats.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Almonds

Trials testing the same drug.

Other recruiting trials for Nutrition, Healthy

Currently open trials in the same condition.

Other University of California, Davis trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05782218.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing